The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world

Sakti Chakrabarti; Marie Parish; Carrie Peterson; Kirk A Ludwig; Deepika Sriram; Antony Ruggeri; Sameer Tolay; Jennifer Ava Selfridge; David L. Bajor; Amr Mohamed; Amit Mahipal; Aditya V Shreenivas; Aurora Complex General Surgical Oncology Faculty; Antony Ruggeri

doi:10.1200/JCO.2023.41.4_suppl.105

The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world

Sakti Chakrabarti, Marie Parish, Carrie Peterson, Kirk A Ludwig, Deepika Sriram, Antony Ruggeri, Sameer Tolay, Jennifer Ava Selfridge, David L. Bajor, Amr Mohamed, Amit Mahipal, Aditya V Shreenivas, Aurora Complex General Surgical Oncology Faculty, Antony Ruggeri

Complex General Surgical Oncology Faculty at Aurora

Advocate Aurora Health

Research output: Contribution to journal › Meeting abstract

Original language	American English
Journal	Journal of Clinical Oncology
DOIs	https://doi.org/10.1200/JCO.2023.41.4_suppl.105
Status	Published - Feb 1 2023

Keywords

neoadjuvant immunotherapy
dMMR/MSI-H colon cancer
oligometastatic colon cancer

Access to Document

10.1200/JCO.2023.41.4_suppl.105License: Unspecified

https://libkey.io/libraries/1712/10.1200/JCO.2023.41.4_suppl.105

Cite this

Chakrabarti, S., Parish, M., Peterson, C., Ludwig, K. A., Sriram, D., Ruggeri, A., Tolay, S., Selfridge, J. A., Bajor, D. L., Mohamed, A., Mahipal, A., Shreenivas, A. V., Complex General Surgical Oncology Faculty, A., & Ruggeri, A. (2023). The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2023.41.4_suppl.105

The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world. / Chakrabarti, Sakti; Parish, Marie; Peterson, Carrie et al.
In: Journal of Clinical Oncology, 01.02.2023.

Research output: Contribution to journal › Meeting abstract

Chakrabarti, S, Parish, M, Peterson, C, Ludwig, KA, Sriram, D, Ruggeri, A, Tolay, S, Selfridge, JA, Bajor, DL, Mohamed, A, Mahipal, A, Shreenivas, AV, Complex General Surgical Oncology Faculty, A & Ruggeri, A 2023, 'The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world', Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2023.41.4_suppl.105

@article{1229e821a3624cf28586e3a9ca955909,

title = "The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world",

keywords = "neoadjuvant immunotherapy, dMMR/MSI-H colon cancer, oligometastatic colon cancer",

author = "Sakti Chakrabarti and Marie Parish and Carrie Peterson and Ludwig, \{Kirk A\} and Deepika Sriram and Antony Ruggeri and Sameer Tolay and Selfridge, \{Jennifer Ava\} and Bajor, \{David L.\} and Amr Mohamed and Amit Mahipal and Shreenivas, \{Aditya V\} and \{Complex General Surgical Oncology Faculty\}, Aurora and Antony Ruggeri",

note = "Chakrabarti S, Parish M, Peterson C, et al. The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world. Journal of Clinical Oncology. 2023;41:105. doi:10.1200/JCO.2023.41.4\_suppl.105",

year = "2023",

month = feb,

day = "1",

doi = "10.1200/JCO.2023.41.4\_suppl.105",

language = "American English",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world

AU - Chakrabarti, Sakti

AU - Parish, Marie

AU - Peterson, Carrie

AU - Ludwig, Kirk A

AU - Sriram, Deepika

AU - Ruggeri, Antony

AU - Tolay, Sameer

AU - Selfridge, Jennifer Ava

AU - Bajor, David L.

AU - Mohamed, Amr

AU - Mahipal, Amit

AU - Shreenivas, Aditya V

AU - Complex General Surgical Oncology Faculty, Aurora

AU - Ruggeri, Antony

N1 - Chakrabarti S, Parish M, Peterson C, et al. The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world. Journal of Clinical Oncology. 2023;41:105. doi:10.1200/JCO.2023.41.4_suppl.105

PY - 2023/2/1

Y1 - 2023/2/1

KW - neoadjuvant immunotherapy

KW - dMMR/MSI-H colon cancer

KW - oligometastatic colon cancer

UR - https://institutionalrepository.aah.org/auroragme/225

UR - https://libkey.io/libraries/1712/10.1200/JCO.2023.41.4_suppl.105

U2 - 10.1200/JCO.2023.41.4_suppl.105

DO - 10.1200/JCO.2023.41.4_suppl.105

M3 - Meeting abstract

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world

Keywords

Access to Document

Other files and links

Cite this